Charles W. Olson, Senior VP of Business Development, Med Development at SURMODICS INC (SRDX), sold 648 shares at $59.75 ($39K) on 2021-04-16, disclosed to the SEC on 2021-04-20.
Scheduled sale ($39k) by Senior VP of Business Development, Med Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SRDX | SELL | 2021-04-02 | $540K | — | Filing → |
| SRDX | SELL | 2018-06-13 | $550K | — | Filing → |
| SRDX | SELL | 2018-05-29 | $1.9M | — | Filing → |